Exicure, Inc. (LSX:A40L5C) Financings
Financings
| Raise | Date |
|---|---|
| Strategic investment of shares of common stock Closed: US$8.7M raised Use of proceeds: Mainly the acquisition of GPCR USA, clinical trial costs and ongoing operations | Dec 26, 2024 |
| Raise | Date |
|---|---|
| Strategic investment of shares of common stock Closed: US$8.7M raised Use of proceeds: Mainly the acquisition of GPCR USA, clinical trial costs and ongoing operations | Dec 26, 2024 |